Report Overview

Global Allergy & Immunology Market- Industry Trends & Forecast Report 2027

The global allergy & immunology market was worth USD 2.1 billion in 2020 and is forecast to reach USD 4.5 billion by 2027, growing at a CAGR of 11.2% in the forecast period. The growth of the global allergy & immunology market is attributable to factors such as the growing prevalence of allergic disorders, increasing air pollution, and the emergence of various diagnosis procedures for allergies. Furthermore, the increasing prevalence of allergies, especially in western countries, is boosting research and development activities for effective control and treatment, driving the growth of the allergy & immunology market.

Source: BlueWeave Consulting

Global Allergy & Immunology Market- Overview

An allergy occurs when the body reacts to a substance in the environment that is harmless to others. It is a condition in which the body's immune system responds to a harmless foreign substance, also known as allergens. Many substances, such as dust, mold, pollen, etc., can cause allergic reactions in people, including frequent wheezing, itchiness, runny noses, itchy eyes, etc. Immunology is the study of the immune system and how it protects the body against infectious diseases.

Global Allergy & Immunology Market Forecast and Trends

Growth Drivers

Increasing Prevalence of Food Allergies in Developed Countries

Food allergies are becoming more common over the world, particularly in Western countries. According to estimates, food allergies affect roughly 7% of children in the United Kingdom, 9% of people in Australia, and 2% of adults in Europe. Allergies are usually not fatal. However, food allergies raise dietary restrictions, which can induce worry and anxiety in people. As a result, the demand for allergy treatments is increasing at a high rate, propelling the growth of the global market.

Expanding Research and Development Activities Regarding Allergy and Immunology

The research institutes and pharmaceutics companies are aggressively engaging in research and development activities towards finding the root causes of allergies, symptom patterns and developing their treatment. Such developments are expected to boost the demand for allergy and immunotherapy in the upcoming years. For example, a new study report published in Pediatric Allergy and Immunology investigates patterns of clinical symptoms and comorbidities in children with allergic rhinitis. Such research aids in optimizing treatments by providing a deeper understanding of allergies and their patterns in distinct demographics.

Restraints

Lack of Awareness Towards Allergy and Immunotherapy

Allergies often result from immune responses to certain substances that do not cause any life-changing symptoms. As a result, most allergic people do not seek medical treatment for allergies. The lack of awareness among people regarding allergy treatment and immunotherapy is one of the major restraining factors for the global allergy & immunology market. Moreover, the symptoms of allergies can easily be confused with those of other problems, such as common cold, sore throat, etc., hindering the market growth.

Impact of COVID-19 on Global Allergy & Immunology Market

The COVID-19 pandemic had little impact on the global allergy & immunology market. The COVID-19 lockdown affected several industries, completely disrupting their production and supply channels, resulting in losses. Allergy& immunology market belongs to the pharmaceutical sector, which was under essential services throughout the pandemic. Thus, despite the lockdown, the industry was able to function at full capacity, which kept the market going. Furthermore, research and development activities flourished significantly and pharmaceutical companies strengthened their online distribution channel, which significantly proliferated the growth of the global allergy & immunology market despite the pandemic.

Global Allergy & Immunology Market - By Treatment Type

Based on treatment types, the global allergy & immunology market is segmented into subcutaneous immunotherapy(SCIT) and sublingual immunotherapy (SLIT). In terms of revenue, the subcutaneous immunotherapy (SCIT) segment dominates the market since it is highly effective for polyallergic patients and also provides lasting protection against asthma. SCIT also can prevent the onset of allergies and asthma. That is why the SCIT segment is growing at a high rate. Furthermore ,the growth of the SCIT segment is also being influenced by increasing research activities.

Global Allergy & Immunology Market - By Allergy Type

Based on allergy types, the global allergy & immunology market is segmented into allergic rhinitis, allergic asthma, and other allergies. Among these, the allergic rhinitis segment holds the largest market share. Allergic rhinitis is often characterized by symptoms such as frequent sneezing or running nose. According to an estimate, around 10 to 30% of US adults and about 40% of children are affected by allergic rhinitis. The high demographic is a significant force behind the rapid growth of the segment.

Global Allergy & Immunology Market - Regional Insights

Geographically, the global allergy & immunology market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. Europe accounts for the largest share in the market, followed by North America. Researchers claim that allergies are more prevalent in developed countries due to western lifestyles. Because European countries such as Germany, Italy, and Norway are prone to allergies, Europe dominates the global allergy & immunology market. The US also has a strong prevalence of varying degrees of food allergies, which is why North America also represents a substantial share of the market.

Competitive Landscape

The leading players in the global allergy & immunology market are ALK-Abello A/S, Teva Pharmaceutical Industries, AbbVie Inc., Stallergenes Greer PLC, Allergy Therapeutics, Sanofi SA, Anacor Pharmaceuticals Inc., Novartis International AG, AstraZeneca, Merck KGaA, F. Hoffmann-La Roche Ltd, Leti Pharma, Galderma SA, Johnson & Johnson, GlaxoSmithKline PLC, Circassia, DESENTUM OY, HAL Allergy B.V., Mylan N.V., and other prominent players.

The global allergy & immunology market is highly consolidated with the presence of several global as well as regional industry players. Market participants have been continually investing in R&D activities to develop treatments that alleviate various types of allergy symptoms. Furthermore, the adoption of competitive strategies like partnerships, mergers, collaborations, acquisitions is also very prominent in this market.

Recent Developments

• In June 2021, Immune ID, Inc., a precision immunology company, announced to have raised USD 50 million in Series A financing, which is aimed towards advancements in the treatment of autoimmune diseases, severe allergies, infectious diseases, and cancer.

• In June 2021, Bayer, a German Pharmaceutics company, announced that it received US FDA approval for Astepro Allergy as an over-the-counter (OTC) product for allergy relief.

Scope of the Report

By Treatment Type

• Subcutaneous Immunotherapy (SCIT)

• Sublingual Immunotherapy (SLIT)

• Tablets

• Drops

By Allergy Type

• Allergic Rhinitis

• Allergic Asthma

• Other Allergies

By Distribution Channel

• Hospital Pharmacy

• Retail Pharmacy

• Online Pharmacy

By Region

• North America

• Europe

• The Asia-Pacific

• Latin America

• Middle East & Africa

1. Research Framework
   1. Research Objective
   2. Product Overview
   3. Key Market Segments
2. Research Methodology
   1. Qualitative Research
   2. Methodology
   3. Regional Split of Primary & Secondary Research
   4. Secondary Research
   5. Primary Research
      1. Breakdown of Primary Research Respondents, By Region
      2. Breakdown of Primary Research Respondents, By Industry Participants
   6. Market Size Estimation
   7. Assumptions for the Study
   8. Market Breakdown & Data Triangulation
3. Executive Summary
4. Industry Insight and Growth Strategy
   1. Value Chain Analysis
   2. DROC Analysis
      1. Market Drivers
         1. Increasing Prevalence of Food Allergies In Developed Countries
         2. Expanding Research and Development Activities Regarding Allergy and Immunology
      2. Market Restraints
         1. Lack of Awareness Towards Allergy and Immunotherapy
      3. Market Challenges
         1. High Cost of Allergy Treatment
      4. Market Opportunity
         1. Increasing Prevalence of Autoimmune diseases
         2. Availability of Wide Range of Allergy Treatment Drugs
   3. Recent Developments
   4. Porter’s Five Forces Analysis
      1. Bargaining Power of Buyers
      2. Bargaining Power of Suppliers
      3. Intensity of Rivalry
      4. Threat of New Entrants
      5. Threat of Substitutes
5. Global Allergy & Immunology Market Overview
   1. Market Size & Forecast by Value, 2017-2027
   2. Market Size and Forecast, By Segment
      1. By Treatment Type
         1. Subcutaneous Immunotherapy (SCIT)
         2. Sublingual Immunotherapy (SLIT)
            1. Tablets
            2. Drops
      2. By Allergy Type
         1. Allergic Rhinitis
         2. Allergic Asthma
         3. Other Allergies
      3. By Distribution Channel
         1. Hospital Pharmacy
         2. Retail Pharmacy
         3. Online Pharmacy
      4. By Region
         1. North America
         2. Europe
         3. The Asia-Pacific
         4. Latin America
         5. The Middle East &Africa
6. North America Allergy & Immunology Market Overview
   1. Market Size and Forecast
      1. By Value (USDBillion), 2020-2027
   2. Market Share and Forecast
      1. By Treatment Type
      2. By Allergy Type
      3. By Distribution Channel
      4. By Country
         1. U.S.
         2. Canada
7. Europe Allergy & Immunology Market Overview
   1. Market Size and Forecast
      1. By Value (USDBillion), 2020-2027
   2. Market Share and Forecast
      1. By Treatment Type
      2. By Allergy Type
      3. By Distribution Channel
      4. By Country
         1. Germany
         2. U.K.
         3. Russia
         4. France
         5. Italy
         6. Spain
         7. Rest of Europe
8. APAC Allergy & Immunology Market Overview
   1. Market Size and Forecast
      1. By Value (USDBillion), 2020-2027
   2. Market Share and Forecast
      1. By Treatment Type
      2. By Allergy Type
      3. By Distribution Channel
      4. By Country
         1. China
         2. India
         3. Japan
         4. South Korea
         5. Rest of APAC
9. LATAM Allergy & Immunology Market Overview
   1. Market Size and Forecast
      1. By Value (USDBillion), 2020-2027
   2. Market Share and Forecast
      1. By Treatment Type
      2. By Allergy Type
      3. By Distribution Channel
      4. By Country
         1. Mexico
         2. Brazil
         3. Rest of LATAM
10. MEA Allergy & Immunology Market Overview
    1. Market Size and Forecast
       1. By Value (USDBillion), 2020-2027
    2. Market Share and Forecast
    3. By Treatment Type
    4. By Allergy Type
    5. By Distribution Channel
    6. By Country
       1. Saudi Arabia
       2. UAE
       3. South Africa
       4. Rest of MEA
11. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Market Share Analysis (2020)
    3. Competitive Benchmarking By Operating Parameters
12. Impact of COVID-19 on Global Allergy & Immunology Market
13. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
    1. ALK-Abello A/S
    2. Teva Pharmaceutical Industries
    3. AbbVie Inc.
    4. Stallergenes Greer PLC
    5. Allergy Therapeutics
    6. Sanofi SA
    7. Anacor Pharmaceuticals Inc.
    8. Novartis International AG
    9. AstraZeneca
    10. Merck KGaA
    11. F. Hoffmann-La Roche Ltd
    12. Leti Pharma
    13. Galderma SA
    14. Johnson & Johnson
    15. GlaxoSmithKline PLC
    16. Circassia
    17. DESENTUM OY
    18. HAL Allergy B.V.
    19. Mylan N.V.
    20. Other Prominent Players
14. Key Strategic Recommendations

List of Figures

Figure 1: Global Allergy & Immunology Segmentation

Figure 2: Global Allergy & Immunology Market Value Chain Analysis,

Figure 3: Company Market Share Analysis, 2020

Figure 4: Global Allergy & Immunology Market Size, By Value (USD Billion), 2020-2027

Figure 5: Global Allergy & Immunology Market Share (%), By Treatment Type, By Value, 2020-2027

Figure 6: Global Allergy & Immunology Market Share (%), By Allergy Type, By Value, 2020-2027

Figure 7: Global Allergy & Immunology Market Share (%), By Distribution Channel, By Value, 2020-2027

Figure 8: Global Allergy &Immunology Market Share (%), By Region, By Value, 2020-2027

Figure 9: North America Allergy & Immunology Market Size, By Value (USD Billion), 2020-2027

Figure 10: North America Allergy & Immunology Market Share (%), By Treatment Type, By Value, 2020-2027

Figure 11: North America Allergy & Immunology Market Share (%), By Allergy Type, By Value, 2020-2027

Figure 12: North America Allergy & Immunology Market Share (%), By Distribution Channel, By Value, 2020-2027

Figure 13: North America Allergy & Immunology Market Share (%), By Country, By Value, 2020-2027

Figure 14: Europe Allergy & Immunology Market Size, By Value (USD Billion), 2020-2027

Figure 15: Europe Allergy & Immunology Market Share (%), By Treatment Type, By Value, 2020-2027

Figure 16: Europe Allergy & Immunology Market Share (%), By Allergy Type, By Value, 2020-2027

Figure 17: Europe Allergy & Immunology Market Share (%), By Distribution Channel, By Value, 2020-2027

Figure 18: Europe Allergy & Immunology Market Share (%), By Country, By Value, 2020-2027

Figure 19: the Asia-Pacific Allergy & Immunology Market Size, By Value (USD Billion), 2020-2027

Figure 20: the Asia-Pacific Allergy & Immunology Market Share (%), By Treatment Type, By Value, 2020-2027

Figure 21: the Asia-Pacific Allergy & Immunology Market Share (%), By Allergy Type, By Value, 2020-2027

Figure 22: the Asia-Pacific Allergy & Immunology Market Share (%), By Distribution Channel, By Value, 2020-2027

Figure 23: the Asia-Pacific Allergy & Immunology Market Share (%), By Country, By Value, 2020-2027

Figure 24: Latin America Allergy & Immunology Market Size, By Value (USD Billion), 2020-2027

Figure 25: Latin America Allergy & Immunology Market Share (%), By Treatment Type, By Value, 2020-2027

Figure 26: Latin America Allergy & Immunology Market Share (%), By Allergy Type, By Value, 2020-2027

Figure 27: Latin America Allergy & Immunology Market Share (%), By Distribution Channel, By Value, 2020-2027

Figure 28: Latin America Allergy & Immunology Market Share (%), By Country, By Value, 2020-2027

Figure 29: Middle East & Africa Allergy & Immunology Market Size, By Value (USD Billion), 2020-2027

Figure 30: Middle East & Africa Allergy & Immunology Market Share (%), By Treatment Type, By Value, 2020-2027

Figure 31: Middle East & Africa Allergy & Immunology Market Share (%), By Allergy Type, By Value, 2020-2027

Figure 32: Middle East & Africa Allergy & Immunology Market Share (%), By Distribution Channel, By Value, 2020-2027

Figure33: Middle East & Africa Allergy & Immunology Market Share (%), By Region, By Value, 2020-2027

List of Tables

Table 1: Global Allergy & Immunology Market Size, By Treatment Type, By Value, 2020-2027

Table 2: Global Allergy & Immunology Market Size, By Allergy Type, By Value(USD Billion), 2020-2027

Table 3: Global Allergy & Immunology Market Size, By Distribution Channel, By Value(USD Billion), 2020-2027

Table 4: Global Allergy & Immunology Market Size, By Region, By Value(USD Billion), 2020-2027

Table 5: North America Allergy & Immunology Market Size, By Treatment Type, By Value (USD Billion), 2020-2027

Table 6: North America Allergy & Immunology Market Size, By Allergy Type, By Value (USD Billion), 2020-2027

Table 7: North America Allergy & Immunology Market Size, By Distribution Channel, By Value (USD Billion), 2020-2027

Table 8: North America Allergy & Immunology Market Size, By Country, By Value (USD Billion), 2020-2027

Table 9: Europe Allergy & Immunology Market Size, By Treatment Type, By Value (USD Billion), 2020-2027

Table 10: Europe Allergy & Immunology Market Size, By Allergy Type, By Value (USD Billion), 2020-2027

Table 11: Europe Allergy & Immunology Market Size, By Distribution Channel, By Value (USD Billion), 2020-2027

Table 12: Europe Allergy & Immunology Market Size, By Country, By Value (USD Billion), 2020-2027

Table 13: the Asia-Pacific Allergy & Immunology Market Size, By Treatment Type, By Value (USD Billion), 2020-2027

Table 14: the Asia-Pacific Allergy & Immunology Market Size, By Allergy Type, By Value (USD Billion), 2020-2027

Table 15: the Asia-Pacific Allergy & Immunology Market Size, By Distribution Channel, By Value (USD Billion), 2020-2027

Table 16: the Asia-Pacific Allergy & Immunology Market Size, By Country, By Value (USD Billion), 2020-2027

Table 17: Latin America Allergy & Immunology Market Size, By Treatment Type, By Value (USD Billion), 2020-2027

Table 18: Latin America Allergy & Immunology Market Size, By Allergy Type, By Value (USD Billion), 2020-2027

Table 19: Latin America Allergy & Immunology Market Size, By Distribution Channel, By Value (USD Billion), 2020-2027

Table 20: Latin America Allergy & Immunology Market Size, By Country, By Value (USD Billion), 2020-2027

Table 21: The Middle-East & Africa Allergy & Immunology Market Size, By Treatment Type, By Value (USD Billion), 2020-2027

Table 22: The Middle-East & Africa Allergy & Immunology Market Size, By Allergy Type, By Value (USD Billion), 2020-2027

Table 23: The Middle-East & Africa Allergy & Immunology Market Size, By Distribution Channel, By Value (USD Billion), 2020-2027

Table 24: The Middle-East & Africa Allergy & Immunology Market Size, By Country, By Value (USD Billion), 2020-2027

Table 25: ALK-Abello A/S Financial Analysis

Table 26: ALK-Abello A/S Business Overview

Table 27: Teva Pharmaceutical Industries Financial Analysis

Table 28: Teva Pharmaceutical IndustriesBusiness Overview

Table 29: AbbVie Inc. Corporation Financial Analysis

Table 30: AbbVie Inc. Corporation Business Overview

Table 31: Stallergenes Greer PLCFinancial Analysis

Table 32: Stallergenes Greer PLC Business Overview

Table 33: Allergy Therapeutics Financial Analysis

Table 34: Allergy Therapeutics Business Overview

Table 35: Sanofi SA Financial Analysis

Table 36: Sanofi SA Business Overview

Table 37: Anacor Pharmaceuticals Inc. Financial Analysis

Table 38: Anacor Pharmaceuticals Inc. Business Overview

Table 39: Novartis International AG Financial Analysis

Table 40:Novartis International AG Business Overview

Table 41: AstraZeneca Financial Analysis

Table 42: AstraZeneca Business Overview

Table 43: Merck KGaAFinancial Analysis

Table 44: Merck KGaA Business Overview

Table 45: F. Hoffmann-La Roche LtdFinancial Analysis

Table 46: F. Hoffmann-La Roche Ltd Financial Analysis

Table 47: Leti PharmaFinancial Analysis

Table 48: Leti Pharma Financial Analysis

Table 49: Galderma SA Financial Analysis

Table 50: Galderma SA  Financial Analysis

Table 51: Johnson & JohnsonFinancial Analysis

Table 52: Johnson & Johnson Financial Analysis

Table 53: GlaxoSmithKline PLCFinancial Analysis

Table 54: GlaxoSmithKline PLC Financial Analysis

Table 55: CircassiaFinancial Analysis

Table 56: Circassia Financial Analysis

Table 57: DESENTUM OYFinancial Analysis

Table 58: DESENTUM OY Financial Analysis

Table 59: HAL Allergy B.V.Financial Analysis

Table 60: HAL Allergy B.V. Financial Analysis

Table 61: Mylan N.V.Financial Analysis

Table 62: Mylan N.V. Financial Analysis